Should patients with hepatic fibrosis undergo LVAD implantation: A comparative analysis

Linnea Xuereb; Pauline H. Go; Babbaljeet Kaur; Silvy Akrawe; Jamil Borgi; Gaetano Paone; Jeffrey A. Morgan

doi:10.1097/MAT.0000000000000375

Should patients with hepatic fibrosis undergo LVAD implantation: A comparative analysis

Linnea Xuereb, Pauline H. Go, Babbaljeet Kaur, Silvy Akrawe, Jamil Borgi, Gaetano Paone, Jeffrey A. Morgan

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

The purpose of our study was to evaluate outcomes in patients with hepatic fibrosis at the time of LVAD implantation. There were five (2.1%) patients with preoperative hepatic fibrosis with a mean age of 51.2 ± 16.8 years. Survival at 180 days was significantly reduced in patients with hepatic fibrosis, 40.0% vs. 88.0%; p = 0.001. Hepatic fibrosis was a significant independent predictor of mortality in multivariate analysis (hazard ratio [HR] 2.27, p = 0.036).

Original language	English (US)
Pages (from-to)	498-500
Number of pages	3
Journal	ASAIO Journal
Volume	62
Issue number	4
DOIs	https://doi.org/10.1097/MAT.0000000000000375
State	Published - Aug 1 2016

All Science Journal Classification (ASJC) codes

Biophysics
Bioengineering
Biomaterials
Biomedical Engineering

Access to Document

10.1097/MAT.0000000000000375

Cite this

@article{c56fbaa102e34e8f931ef6a935d7f854,

title = "Should patients with hepatic fibrosis undergo LVAD implantation: A comparative analysis",

abstract = "The purpose of our study was to evaluate outcomes in patients with hepatic fibrosis at the time of LVAD implantation. There were five (2.1%) patients with preoperative hepatic fibrosis with a mean age of 51.2 ± 16.8 years. Survival at 180 days was significantly reduced in patients with hepatic fibrosis, 40.0% vs. 88.0%; p = 0.001. Hepatic fibrosis was a significant independent predictor of mortality in multivariate analysis (hazard ratio [HR] 2.27, p = 0.036).",

author = "Linnea Xuereb and Go, {Pauline H.} and Babbaljeet Kaur and Silvy Akrawe and Jamil Borgi and Gaetano Paone and Morgan, {Jeffrey A.}",

note = "Publisher Copyright: {\textcopyright} 2016 by the American Society for Artificial Internal Organs.",

year = "2016",

month = aug,

day = "1",

doi = "10.1097/MAT.0000000000000375",

language = "English (US)",

volume = "62",

pages = "498--500",

journal = "ASAIO Journal",

issn = "1058-2916",

publisher = "Lippincott Williams and Wilkins",

number = "4",

}

TY - JOUR

T1 - Should patients with hepatic fibrosis undergo LVAD implantation

T2 - A comparative analysis

AU - Xuereb, Linnea

AU - Go, Pauline H.

AU - Kaur, Babbaljeet

AU - Akrawe, Silvy

AU - Borgi, Jamil

AU - Paone, Gaetano

AU - Morgan, Jeffrey A.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - The purpose of our study was to evaluate outcomes in patients with hepatic fibrosis at the time of LVAD implantation. There were five (2.1%) patients with preoperative hepatic fibrosis with a mean age of 51.2 ± 16.8 years. Survival at 180 days was significantly reduced in patients with hepatic fibrosis, 40.0% vs. 88.0%; p = 0.001. Hepatic fibrosis was a significant independent predictor of mortality in multivariate analysis (hazard ratio [HR] 2.27, p = 0.036).

AB - The purpose of our study was to evaluate outcomes in patients with hepatic fibrosis at the time of LVAD implantation. There were five (2.1%) patients with preoperative hepatic fibrosis with a mean age of 51.2 ± 16.8 years. Survival at 180 days was significantly reduced in patients with hepatic fibrosis, 40.0% vs. 88.0%; p = 0.001. Hepatic fibrosis was a significant independent predictor of mortality in multivariate analysis (hazard ratio [HR] 2.27, p = 0.036).

UR - http://www.scopus.com/inward/record.url?scp=84977997061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84977997061&partnerID=8YFLogxK

U2 - 10.1097/MAT.0000000000000375

DO - 10.1097/MAT.0000000000000375

M3 - Article

C2 - 27014788

AN - SCOPUS:84977997061

SN - 1058-2916

VL - 62

SP - 498

EP - 500

JO - ASAIO Journal

JF - ASAIO Journal

IS - 4

ER -

Should patients with hepatic fibrosis undergo LVAD implantation: A comparative analysis

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this